NEW YORK (AP) -- Shares of molecular diagnostics company Cepheid rose Tuesday after the company said that demand for several of its GeneXpert tests were stronger than expected. THE SPARK: Cepheid said ...

So far, this has been a tough quarter for some of the growth darlings of the medical technology sector. It's still somewhat early in the reporting cycle, but Intuitive Surgical (ISRG) and MAKO ...

What: Shares of Cepheid, a molecular diagnostics company, fell by more than 20% today on heavy volume after the company released its preliminary third quarter results. Digging into the quarterly ...

Cepheid (Nasdaq:CPHD) hit a new 52-week high Friday as it changed hands at $27.05 compared with its previous 52-week high of $27. Cepheid is currently trading at $27.05 with 15,126 shares changing ...

Cepheid (Nasdaq:CPHD) hit a new 52-week high Monday as it changed hands at $25.43 compared with its previous 52-week high of $25.25. Cepheid is currently trading at $25.42 with 17,630 shares changing ...

What: Shares of Cepheid (NASDAQ: CPHD), a molecular diagnostics company, fell by more than 20% today on heavy volume after the company released its preliminary third quarter results. Digging into the ...

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30.

What:Shares ofCepheid, a developer of molecular diagnostic tests used in managing infectious diseases and cancer, plunged around 12% today after the company reported its second-quarter earnings ...